GlassScriptPhysician profile
Wallace L Akerley
NPI 1346330966
$37,779.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2021: $4,200 · 2022: $2,800 · 2023: $9,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,300 · Food and Beverage: $125 · Education: $12.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,300.00 |
| Food and Beverage | $125.27 |
| Education | $12.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13,995.23 | 2019-2023 | |
| Eli Lilly and Company | $9,800.00 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $7,319.10 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $4,875.00 | 2023 | |
| Bristol Myers Squibb Company | $1,625.00 | 2023 | |
| Novocure Gmbh | $98.68 | 2023 | Optune |
| Genentech, INC. | $39.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.96 | 2023 | Rybrevant |
10 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Akerley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.